Urgent: Hydroxycut Lawsuits Have Already Been Reported
On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that people using the products were developing heavy liver problems and other health issues. Less than seven days later, on May four, the first Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Case alleges company negligence in informing the public about potential dangers of the products. Naturally, it’s too shortly to grasp the suit is going to turn out, but if the company had information which it did not reveal to buyers, it should definitely be held accountable.
A class action lawsuit is filed by a group of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less expensive, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost anything unless there is a settlement. At that point, the attorney who handled the suit will take his charges from the compensation that was given and then distribute the remaining funds to the litigants in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action legal actions became so popular.
The first class action suit against Iovate was filed in Canada where the company is located and represents all Canadian voters who sustained health issues due to Hydroxycut products. The FDA recall occurred in the US where twenty-three cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning people who sustained respiration, neurological, heart, and gut issues as a consequence of Canadians using the products.
The Hydroxycut Liver Damage Suits alleges the company sold the company sold the general public of the health risks that they could exposing consumers to. The complaint states that the company did not publish the data on the product labels stating that users could run the chance of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological issues. The suit goes on to allege that this was a blatant omission on the part of the company which deliberately misled clients concerning the protection of the products.
